Sunday, October 25, 2009

Para-pneumonic effusion and Empyema

-Patho-physiology:

Capillary Leak/ Exaudate stage

Bacterial Invasion/ Fibrinolytic stage

Organization/ Empyema stage

Mechanism:

Micro-organisms à PMNs à O2 free radicals + products à endothelial injury à ñ capillary permeability à ñ interstitial/pleural pressure gradient (subpleural) à effusion

Mechanism:

ññ endothelial injury with bacterial multiplication over whelming lymphatics, MQ, neutrophils

Mechanism:

Continuous fibroblastic migration from visceral, parietal pl. à coagulable pleural matrix (inelastic membrane or pleural peel) à thick cavity 'e thick yellowish white opaque viscous pus

Fluid ccc:

· Ipsilateral,Small, Free

· Sterile (-ve gram and culture)

· Predominant PNLs

· PH > 7.2, exaudate

· Glucose > 60 mg

· LDH > 500 IU/L

· Appears in 2-5 ds of pneumonia onset

Fluid ccc:

· Cloudy fluid

· +ve gram and culture

for bacteria

· ññ PNLs, debris

· PH between 7-7.2

· Glucose < 40 mg/dl

· LDH > 1000 (lysis)

· In 5-10 ds of pneumonia onset

Fluid ccc:

· Pus ± foul smelling

· G-ve (30%), staph (10-25%), strept. malleri, anaerobes (bacteroids, peptost), mixed infection, or sterile pus in 1/3 cases

· Staph, H.I. in children

· In 2-3 weeks of pn.

-Classification:

I. Non significant parapneumonic effusion:

II. Typical exaudative effusion (uncomplicated):

III. Borderline complicated effusion:

IV. Simple complicated (Fibrinolytic):

V. Complex complicated effusion:

VI. Simple empyema:

VII. Complex empyema:

-Differential Diagnosis:

Empyema

Abscess

CXR

-Displaces bronchial, vascular markings

-Cross major fissures

-Unequal width of air-fluid level in P/A and lateral views

-No displacement

-Follows anatomical rules

-Equal width in both

CT

-Smooth rounded outline

-Acute angle between empyema and pleural margin

-Compresses lung

-Pleural split sign à walls of visceral & parietal pleurae are separate (2 contrasts)

-Oval irregular outline

-Obtuse angle

-No compression

-No pleural split sign

*For full text --> download from: ParaPneumonic Effusion.pdf

Friday, October 23, 2009

Plague (black death)

-Definition:

It is a zoonotic disease circulating mainly among small animals and their fleas caused by Yersinia pestis bacteria (G-ve cocco-bacillus belongs to enterobacterecea) which rarely infects humans.

-Modes of Transmission:

It is transmitted between animals and humans by:

· Infected flea bite à bubonic plague

· Direct contact à septicaemic plague

· Inhalation à pneumonic plague

· Ingestion of infective materials (rare) à septicaemic plague

-Incubation Period:

1-3 days (pneumonic) or 2-6 days (bubonic)

-Clinical Picture:

1- Always begin by "flu like symptoms":

  • General malaise

· High fever (hyperpyrexia) and Chills

· Headache and Body aches

· Nausea and Vomiting

2- Develop one of the "3 forms" according to the route of infection:

Bubonic plague: (the most common) Septicaemic plague Pneumonic plague: (the most virulent and least common)

-Complications: mainly to bubonic and septicaemic forms:

· DIC

· Meningitis and Convulsions

· Endotoxic Shock (a cause of death)

· Septic Shock from sever pneumonic form (a cause of death)

-Treatment:

Rapid treatment is critical for survival as: (within 24 hrs)

*Without Treatment, fatality rates: up to 90% for bubonic plague, 100% for septicaemic or pneumonic plague.

*With Treatment, fatality rate= 5-20%.

Drugs used: Streptomycin is the drug of choice; then Gentamycin, Doxycycline and Ciprofloxacin; but ß-lactams are not useful + Supportive treatment as O2, IV fluids, Respiratory support …etc.

*For Full Text --> download from: Plague.pdf

Tuesday, October 6, 2009

Pneumonia

-Definition: Syndrome caused by acute infection of the lung parenchyma characterized by clinical and radiological signs of consolidation of parts or part of one or both lungs.

*For more details --> download from: Pneumonia.pdf

Download files

Highlighted Topic

Idiopathic Pulmonary Fibrosis Updates 2015

More presentations from Dr Riham

About Me

My photo
Cairo, Egypt
Lecturer of Chest Diseases JOIN ME IN: https://www.facebook.com/groups/PulmonaryMedicine/ http://www.facebook.com/drrihamchest/

Followers